glp 1 and inflammatory arthritis Glucagon-like Peptide-1 Receptor Agonists in Rheumatoid Arthritis: A Scoping Review of Metabolic, Anti-Inflammatory, Cardioprotective Effects The potential role of GLP‐1

People using these medicines can lose more weight than with diet and exercise alone a loss of between 5% and 21% of their body weight can be expected depending on which medicine is taken and how long it is used

Withdrawals must be predictable, and identity checks should feel structured rather than intrusive

Avoid skipping meals entirely, as this can exacerbate both headaches and other GLP-1 side effects

For example, eating more slowly, avoiding fatty foods, and increasing your water intake can help relieve nausea and vomiting

Clinical Timeline From STEP Trials Fatigue is the second most common non-gastrointestinal side effect of Wegovy after headache, based on data from the STEP clinical trials program